Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

74.99
Delayed Data
As of May 27
 -0.53 / -0.70%
Today’s Change
67.88
Today|||52-Week Range
92.85
-11.00%
Year-to-Date
Lilly's (LLY) R&D Update, Targets 20 New Launches by 2023
May 25 / Zacks.com - Paid Partner Content
'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market
May 22 / GuruFocus News - Paid Partner Content
2 Promising Biopharmas Reach Key Junctures
May 23 / TheStreet.com - Paid Partner Content
Agilent's Unit Dako Expands the Use of PD-L1 Test in Europe
May 16 / Zacks.com - Paid Partner Content
Big Hedge Funds Love These 5 Stocks Big -- Do You?
May 23 / TheStreet.com - Paid Partner Content
Biotech groups sink their teeth into the Big Apple
May 16 / FT.com - Paid Partner Content
Most Bought and Sold Stocks by Hedge Funds
May 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close75.52
Today’s open75.52
Day’s range74.67 - 75.72
Volume3,247,520
Average volume (3 months)4,676,006
Market cap$82.8B
Dividend yield2.72%
Data as of 4:03pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+4.37%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+1.75%
P/E ratio34.4
Price/Sales4.50
Price/Book5.69

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+0.65+0.61%
AZNAstraZeneca-0.07-0.23%
AGNAllergan+3.58+1.54%
ABBVAbbVie+0.81+1.31%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts

Partner Offers

Search for Jobs